Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 16.91 | N/A |
PEG Ratio (TTM) | -0.68 | N/A |
P/S Ratio (TTM) | 11.93 | N/A |
P/B Ratio (TTM) | 3.50 | N/A |
P/FCF Ratio (TTM) | -14.45 | N/A |
Price to 5YR AVG Earnings Ratio | 5.80 | N/A |
Price to 5YR AVG FCF Ratio | -0.36 | N/A |
Profitability (75%) |
Company | Industry |
---|---|---|
ROA (TTM) | 20.63% | N/A |
ROE (TTM) | 21.08% | N/A |
Net Profit Margin (TTM) | 70.56% | N/A |
ROIC 5YR AVG | -0.75% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -10.95% | -14.73% | 60.51% |
Revenue | -16.85% | -22.44% | 53.18% |
Net Income | -13.78% | -18.38% | 61.79% |
Cash Flow | -682.46% | -58.05% | -18,854.00% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 182.09 | N/A |
Quick Ratio (TTM) | 182.09 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |